Quarterly report pursuant to Section 13 or 15(d)

SHARE BASED COMPENSATION (Details)

v3.10.0.1
SHARE BASED COMPENSATION (Details) - Restricted Stock
9 Months Ended
Sep. 30, 2018
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Non-vested, beginning balance, shares | shares 382,873
Vested, shares | shares (201,059)
Forfeited, shares | shares (500)
Non-vested, ending balance, shares | shares 510,185
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Non-vested, beginning balance, Weighted Average Grant Price (USD per share) | $ / shares $ 12.68
Vested, Weighted Average Grant Price (USD per share) | $ / shares 14.05
Forfeited, Weighted Average Grant Price (USD per share) | $ / shares 9.66
Non-vested, ending balance, Weighted Average Grant Price (USD per share) | $ / shares $ 9.77
Non-employee directors  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Restricted stock awards granted, shares | shares 37,272
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Restricted stock awards granted Weighted Average Grant Price (USD per share) | $ / shares $ 9.00
Employees  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Restricted stock awards granted, shares | shares 291,599
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Restricted stock awards granted Weighted Average Grant Price (USD per share) | $ / shares $ 9.00